Praveen P. Govender MB BCh
Assistant Professor, Pulmonary, Allergy, Sleep & Critical Care Medicine
72 E. Concord Street | (617) 638-4814praveen.govender@bmc.org
prgovend@bu.edu

Sections
Pulmonary, Allergy, Sleep & Critical Care Medicine
Centers
Pulmonary Center
Biography
Dr. Praveen Govender is the Associate Director of the Sarcoidosis Center with training in Pulmonary Medicine, Allergy and Immunology. He has worked extensively with Dr. Jeffrey Berman in the care of patients with sarcoidosis since 2008 at The Sarcoidosis Center at Boston Medical Center. Their mission is to improve the lives of persons with sarcoidosis by providing state-of-the-art patient care coupled with innovative research aimed at understanding the pathogenesis and natural history of sarcoidosis. Dr. Govender is an active member of the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG).
Education
MBBCh, Royal College of Surgeons in Ireland
BS, University of Alberta
Publications
Sangani R, Bosch NA, Govender P, Scarpato B, Walkey AJ, Newman J, Law AC, Gillmeyer KR, Shankar DA. Sarcoidosis Treatment Patterns in the United States: 2016-2022. Chest. 2024 Nov 09. PMID: 39522595.
Published on 11/1/2022Cozier YC, Govender P, Berman JS. Obesity and Sarcoidosis Risk: An Index Under Suspicion. Chest. 2022 Nov; 162(5):954-956. PMID: 36344120.
Published on 2/22/2021Lui JK, Mesfin N, Tugal D, Klings ES, Govender P, Berman JS. Critical Care of Patients With Cardiopulmonary Complications of Sarcoidosis. J Intensive Care Med. 2022 Apr; 37(4):441-458. PMID: 33611981.
Published on 10/1/2020Law ST, Jafarzadeh SR, Govender P, Sun X, Sanchorawala V, Kissin EY. Comparison of Ultrasound Features of Major Salivary Glands in Sarcoidosis, Amyloidosis, and Sjögren's Syndrome. Arthritis Care Res (Hoboken). 2020 10; 72(10):1466-1473. PMID: 31309727.
Published on 9/3/2020Govender P, Cozier YC. Sarcoidosis in a time of pandemic. Eur Respir J. 2020 09; 56(3). PMID: 32883761.
Published on 6/30/2020Abston E, Moll M, Hon S, Govender P, Berman J, Farber H. Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertension. Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(2):184-191. PMID: 33093782.
Published on 6/30/2020Abston E, Hon S, Lawrence R, Berman J, Govender P, Farber HW. Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy. Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(2):234-238. PMID: 33093789.
Published on 6/30/2020Nitzberg M, Parikh R, Govender P, Farber HW. Pulmonary hypertension secondary to takayasu's arteritis: management using a combined medical and interventional approach. Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(2):239-241. PMID: 33093790.
Published on 4/15/2020Cozier YC, Govender P. Sarcoidosis: An Ill-afforded Disease. Am J Respir Crit Care Med. 2020 04 15; 201(8):890-891. PMID: 31978312.
Published on 4/15/2020Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, Abston E, Bernstein RC, Blankstein R, Chen ES, Culver DA, Drake W, Drent M, Gerke AK, Ghobrial M, Govender P, Hamzeh N, James WE, Judson MA, Kellermeyer L, Knight S, Koth LL, Poletti V, Raman SV, Tukey MH, Westney GE, Baughman RP. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 04 15; 201(8):e26-e51. PMID: 32293205.